Top-News
Gesundheitswesen USA

Bioelectronics News

Aktie
WKN:  A0J2WS ISIN:  US09062H1086 US-Symbol:  BIEL
0,0002 $
+0,0001 $
+100,00%
31.05.24 20:16:16
Handeln Depot/Watchlist
Aktienanzahl *
2,44 Mrd.
Marktkapitalisierung *
449,81 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 06.09.2021

Bioelectronics News

06.11.20 - PR Newswire
BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage
BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage Drug-Free Pain Relief Technology with Premium Wraps PR Newswire
10.07.19 - ACCESSWIRE
The Stock Day Podcast Hosts BioElectronics' to Discuss Its New Technology To Mitigate Opioid Use
PHOENIX, AZ / ACCESSWIRE / July 10, 2019 / The Stock Day Podcast welcomed BioElectronics Corporation (BIEL) (“the Company”), a leader in non-​invasive electroceuticals and the ...
14.03.19 - PR Newswire
Northwest Specialty Hospital Now Offering Electroceutical Alternative To Opioids In Clinical Practice
Northwest Specialty Hospital Now Offering Electroceutical Alternative To Opioids In Clinical Practice PR Newswire
13.11.18 - ACCESSWIRE
BioElectronics Discusses Advancing the Electroceuticals Market
PHOENIX, AZ/ ACCESSWIRE / November 13th, 2018 / BioElectronics Corporation (OTC PINK: BIEL), is a maker of advanced medical devices. Nalepka, VP of Sales and Marketing, ...
10.10.16 - PR Newswire
BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application
BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application PR Newswire
03.10.16 - PR Newswire
BioElectronics' ActiPatch® Drug-free Pain Therapy to be Featured at Pharmacy Week in Trinidad & Tobago W.I.
BioElectronics' ActiPatch® Drug-free Pain Therapy to be Featured at Pharmacy Week in Trinidad & Tobago W.I. PR Newswire
28.09.16 - PR Newswire
BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication
BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication PR Newswire
11.05.16 - PR Newswire
BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing
BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing PR Newswire
10.05.16 - PR Newswire
BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application
BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application PR Newswire
28.04.16 - PR Newswire
BioElectronics' Drug-free ActiPatch® Pain Therapy
BioElectronics' Drug-free ActiPatch® Pain Therapy Highlighted in UK's Express Newspaper on Dangers of Excessive Drug Use PR Newswire
25.04.16 - PR Newswire
BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section
BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section PR Newswire
11.04.16 - PR Newswire
BioElectronics President Interviewed by the StockRadio.com
BioElectronics President Interviewed by the StockRadio.com Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use PR Newswire
29.03.16 - PR Newswire
BioElectronics Drug-free Chronic Pain Therapy Observation Study Results
BioElectronics Drug-free Chronic Pain Therapy Observation Study Results 61% Pain Reduction & Decreases Medication Use in 86% (including opioids) PR Newswire
21.03.16 - PR Newswire
BioElectronics Appoints Evomed as Australian and New Zealand Distributor
BioElectronics Appoints Evomed as Australian and New Zealand Distributor PR Newswire
15.03.16 - PR Newswire
BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget"
BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget" PR Newswire
09.03.16 - PR Newswire
BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress PR Newswire
18.02.16 - PR Newswire
BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff
BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff PR Newswire
08.02.16 - PR Newswire
BioElectronics Corporation Refutes SEC Order for Administrative Proceedings
BioElectronics Corporation Refutes SEC Order for Administrative Proceedings PR Newswire
05.01.16 - PR Newswire
BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis
BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis PR Newswire
14.12.15 - PR Newswire
BioElectronics Announces Oxford University Sponsored Study
BioElectronics Announces Oxford University Sponsored Study ActiPatch® Therapy for Chronic Low Back Pain PR Newswire

Newssuche

Videos

29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »